Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IL-17A | 100 | ng/mL | 1 | SDF1-a | 91.0 | 34 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | SDF1-a | 77.5 | 40 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | SDF1-a | 99.0 | 47 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | SDF1-a | 81.0 | 36 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | SDF1-a | 55.5 | 38 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | SDF1-a | 64.0 | 57 | |
RA2159 | 1 | SDF1-a | 22.5 | 44 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | SDF1-a | 56.0 | 108 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | SDF1-a | 18.5 | 54 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | SDF1-a | 22.0 | 75 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | SDF1-a | 28.0 | 79 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | SDF1-a | 23.0 | 73 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | SDF1-a | 25.0 | 54 | ||||
N2586 | 1 | SDF1-a | 40.5 | 52 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | SDF1-a | 47.0 | 39 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | SDF1-a | 42.0 | 43 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | SDF1-a | 40.0 | 65 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | SDF1-a | 46.5 | 68 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | SDF1-a | 32.0 | 53 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | SDF1-a | 31.0 | 39 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | SDF1-a | 31.5 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | SDF1-a | 21.0 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | SDF1-a | 23.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | SDF1-a | 33.5 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | SDF1-a | 31.0 | 61 |